Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 48: 2217-2224, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liebisch, G.
Right arrow Articles by Schmitz, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liebisch, G.
Right arrow Articles by Schmitz, G.
Related Collections
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2002;48:2217-2224.)
© 2002 American Association for Clinical Chemistry, Inc.

High-Throughput Quantification of Lysophosphatidylcholine by Electrospray Ionization Tandem Mass Spectrometry

Gerhard Liebisch, Wolfgang Drobnik, Bernd Lieser and Gerd Schmitza

1 Institut für Klinische Chemie und Laboratoriumsmedizin, Universität Regensburg, D-93042 Regensburg, Germany.

aAuthor for correspondence. Fax 49-941-944-6202; e-mail gerd.schmitz{at}klinik.uni-regensburg.de.

Background: Lysophosphatidylcholine (LPC) has been suggested to play a functional role in various diseases, including atherosclerosis, diabetes, and cancer mediated by LPC-specific G-protein-coupled receptors. Initial studies provided evidence for a potential use of LPC as diagnostic maker. However, existing methodologies are of limited value for a systematic evaluation of LPC species concentrations because of complicated, time-consuming procedures. We describe a methodology based on electrospray ionization tandem mass spectrometry (ESI-MS/MS) applicable for high-throughput LPC quantification.

Methods: Crude lipid extracts of EDTA-plasma samples were used for direct flow injection analysis. LPC 13:0 and LPC 19:0 were added as internal standards, and the ESI-MS/MS was operated in the parent-scan mode for m/z 184. Quantification was achieved by standard addition. Data processing was highly automated by use of the mass spectrometer software and self-programmed Excel macros.

Results: The calibrators LPC 16:0, LPC 18:0, and LPC 22:0 showed a linear response independent of sample dilution and plasma cholesterol concentration for both internal standards. The within-run imprecision (CV) was 3% for the major and 12% for the minor species, whereas the total imprecision was ~12% for the major and 25% for the minor species. The detection limit was <1 µmol/L.

Conclusion: The developed ESI-MS/MS methodology with an analysis time of 2 min/sample, simple sample preparation, and automated data analysis allows high-throughput quantification of distinct LPC species from plasma samples, which could be a valuable tool for the evaluation of LPC as diagnostic marker.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
M. Scherer, G. Schmitz, and G. Liebisch
High-Throughput Analysis of Sphingosine 1-Phosphate, Sphinganine 1-Phosphate, and Lysophosphatidic Acid in Plasma Samples by Liquid Chromatography-Tandem Mass Spectrometry
Clin. Chem., June 1, 2009; 55(6): 1218 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
P. Wiesner, K. Leidl, A. Boettcher, G. Schmitz, and G. Liebisch
Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry
J. Lipid Res., March 1, 2009; 50(3): 574 - 585.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
S. Yu, Q. Li, T. M. Badger, and N. Fang
Quantitative Analysis of Polar Lipids in the Nanoliter Level of Rat Serum by Liquid Chromatography/Mass Spectrometry/Mass Spectrometry
Experimental Biology and Medicine, February 1, 2009; 234(2): 157 - 163.
[Abstract] [Full Text] [PDF]

Home page
 Brief Funct Genomic ProteomicHome page
W. Hou, H. Zhou, F. Elisma, S. A. L. Bennett, and D. Figeys
Technological developments in lipidomics
Brief Funct Genomic Proteomic, September 19, 2008; (2008) eln042v1.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
C. Xiao, T. Watanabe, Y. Zhang, B. Trigatti, L. Szeto, P. W. Connelly, S. Marcovina, T. Vaisar, J. W. Heinecke, and G. F. Lewis
Enhanced Cellular Uptake of Remnant High-Density Lipoprotein Particles: A Mechanism for High-Density Lipoprotein Lowering in Insulin Resistance and Hypertriglyceridemia
Circ. Res., July 18, 2008; 103(2): 159 - 166.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Binder, G. Liebisch, T. Langmann, and G. Schmitz
Metabolic Profiling of Glycerophospholipid Synthesis in Fibroblasts Loaded with Free Cholesterol and Modified Low Density Lipoproteins
J. Biol. Chem., August 4, 2006; 281(31): 21869 - 21877.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
B. M. Ham, R. B. Cole, and J. T. Jacob
Identification and comparison of the polar phospholipids in normal and dry eye rabbit tears by maldi-tof mass spectrometry.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3330 - 3338.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
W. Drobnik, G. Liebisch, F.-X. Audebert, D. Frohlich, T. Gluck, P. Vogel, G. Rothe, and G. Schmitz
Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients
J. Lipid Res., April 1, 2003; 44(4): 754 - 761.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.